Health & Medicine
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
The FDA requires all GLP-1 drugs, including Ozempic and Mounjaro, to warn of potential NAION risk, a rare condition causing sudden vision…
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
An analysis of how trial designs focused on immune response metrics bypass FDA requirements, potentially delaying approvals for lifesaving cancer combinations.
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
As Joe Biden scales back public appearances due to metastatic prostate cancer, we examine the clinical realities of high-risk disease and current…
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
Genfit advances TREM-1 modulator into ACLF after prior Phase 2 trials showed safety signals in septic shock and severe COVID-19.
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
Large population study finds SABR linked to higher three-year mortality than surgery, but gap narrows significantly for patients 80 and older.
-
FDA Approves First Antisense Drug Offering Finite Hepatitis B Therapy
Hibsago (bepirovirsen) enables a six-month treatment course that can yield a functional cure, letting some patients stop all antiviral medication.
-
Study Finds Autistic Adults Over 45 Face Nearly Triple Parkinsonism Rates
A U.S. Medicare analysis shows Parkinsonism prevalence of 3.8% in autistic seniors versus 1.6% in peers, highlighting new neurodegenerative risks for the…
-
Why Former Firefighters Face Lingering Psychological Trauma After Leaving the Career
An exploration of how leaving high-stress emergency services impacts mental health, reopening deep psychological wounds during secondary trauma events.
-
Overcoming Immunotherapy Resistance Takes Center Stage at SITC 2026
Researchers at the SITC annual meeting tackle major cancer immunotherapy challenges, from metabolic resistance mechanisms to novel combination trials.
-
How Amivantamab’s Dual EGFR-MET Blockade Overcomes Resistance in Head and Neck Cancer
The first new drug in a decade for advanced HNSCC uses a bispecific antibody to hit two escape pathways at once, doubling…
-
START Opens First Italian Early-Phase Cancer Trial Site in Rome
Strategic partnership establishes first START site in Italy, expanding early-phase cancer trial access to patients in Rome and the Lazio region despite…
-
Personalized TMS Shows Promise for Severe OCD in Singapore Study
NUH and NUS Medicine report early success using fMRI-guided stimulation for treatment-resistant OCD, aiming to extend the method to depression and anxiety.
-
Dhaka Shelter Gives 85 Cancer Patients Beds, Meals and Support
Cancer survivor Albab founded a home providing meals and clean rest for underprivileged patients who cannot afford treatment or stay in overcrowded…
-
Researchers find biological clues to why colorectal cancer strikes young adults
A new cell-by-cell tumor atlas sheds light on the aggressive nature of colorectal cancer in younger populations as screening rates expand.
-
Study Links Louisiana Industrial Pollution to Fourfold Rise in Infant Heart Defects
New research finds babies born in high-pollution areas of southeast Louisiana face significantly higher odds of severe congenital heart defects.
-
Penn study finds patient navigators overcome hidden asthma barriers
A new trial shows trained navigators help low-income adults manage environmental and social obstacles, improving asthma control.
-
UNICORN Trial Finds Deep Responses to Preoperative Immunotherapy
New data from Agenus’ UNICORN trial reveals that short-course neoadjuvant immunotherapy achieves pathologic complete responses in 93% of dMMR colon cancer patients,…
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
New research suggests that consuming sugary foods more than twice a week is associated with a significant increase in breast cancer incidence.
-
Generic HIV Shot Cuts Cost to $40, Unlocking Access in 120 Low-Income Countries
FDA approval of Dr. Reddy’s lenacapavir generic enables affordable, twice-yearly HIV prevention for millions in developing regions.
-
AI Paper Mills Flood Journals With Unverifiable Health Studies, Researchers Warn
Chinese software generates publishable papers in under two hours using public data, but withholds code needed for verification, overwhelming peer review.
-
Major study links moderate alcohol consumption to increased cancer risk and early death
Even one drink a day raises risk of cancer, heart disease and premature death, researchers say, challenging the idea that moderate drinking…
-
Ractigen Launches Phase II Trial for Bladder Cancer Treatment
Ractigen Therapeutics initiates Phase II clinical trial for saRNA therapy RAG-01 to treat non-muscle invasive bladder cancer in China.
-
Blood Cancer UK launches £25m appeal to double leukaemia survival rates
Scientists aim to double leukaemia survival rates using a pioneering multi-treatment clinical trial method that previously transformed prostate cancer care.
-
MIT Nanoparticle Vaccine Tuning Strengthens Immune Responses in Mice
MIT researchers use engineered M13 bacteriophage particles to create more effective cancer vaccines, potentially revolutionizing patient outcomes.
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992